Contents: Click on Link to View
ToggleCatalyst vs. Bull Score
Today's market-moving news.
Bullish Catalysts
Bearish Catalysts
Neutral Catalysts
RunProfits Daily RNS Analysis: 10 July 2025
Part I: Executive Intelligence Summary
Daily Catalyst Monitor
- Bullish:Rank Group, Trifast, CML Microsystems, Atalaya Mining, Hostelworld Group
- Bearish:Macfarlane Group, PageGroup, Liontrust Asset Management, Vistry Group, Central Asia Metals, Polar Capital Holdings
- Neutral:Severn Trent, Johnson Service Group, The Pebble Group, Carclo, DP Poland, Pantheon Resources, Creo Medical Group
- Strategic:Strix Group, DCC
Key Catalysts Identified
Today's trading is dominated by a clear divergence in corporate performance. On one hand, consumer-facing sectors show resilience, with Rank Group (RNK) delivering a significant profit upgrade. On the other, industrials and recruitment firms like Macfarlane (MACF) and PageGroup (PAGE) are issuing profit warnings and highlighting severe market headwinds, reflecting broader economic uncertainty. Asset managers, including Liontrust (LIO) and Polar Capital (POLR), are reporting substantial net outflows, pointing to continued investor caution. A notable contract win for CML Microsystems (CML) provides a standout bullish catalyst in the tech sector.
Performance & Conviction Quadrant
Company | EPIC | Type | Score | Direction | Conviction | Key Rationale |
---|---|---|---|---|---|---|
Rank Group | RNK | Trading Update | +9.0 | Bullish | High | [cite_start]Full-year operating profit now expected to be at least £63m, ahead of expectations. [cite: 630] |
Macfarlane Group | MACF | Trading Update | -10.0 | Bearish | High | [cite_start]Profit warning issued, with full-year adjusted operating profit expected to be ~10% below 2024. [cite: 94] |
PageGroup | PAGE | Trading Update | -8.0 | Bearish | High | [cite_start]Worsening conditions in Europe and a significant headcount reduction signal a tough outlook. [cite: 226, 227, 222] |
CML Microsystems | CML | Contract Win | +8.0 | Bullish | High | [cite_start]Significant 12-year contract valued at over $30 million, providing long-term revenue visibility. [cite: 580] |
Liontrust Asset Management | LIO | Trading Update | -6.0 | Bearish | Medium | [cite_start]Net outflows accelerated to £1.1bn in the quarter, with AuMA remaining stagnant. [cite: 505, 506] |
Trifast | TRI | Final Results | +7.0 | Bullish | Medium | [cite_start]Profit beat expectations, with significant EBIT margin growth and strengthening balance sheet. [cite: 271, 275] |
Part II: Granular Company Analysis
Carclo (CAR)
[cite_start]RNS Catalyst Assessment: A mixed but ultimately neutral announcement, confirming that FY25 trading exceeded expectations but this is overshadowed by a delay in the publication of audited financials and the likely temporary suspension of its shares. [cite: 86, 81, 83]
Metric | Value | Commentary |
---|---|---|
FY25 Trading | Exceeded Expectations | [cite_start]Positive operational performance with strong margin expansion. [cite: 86] |
Net Debt (31 Mar 25) | £19.3m | [cite_start]Significant £10.2m reduction from £29.5m a year prior. [cite: 87] |
Share Suspension | Expected 1 Aug 2025 | [cite_start]Temporary suspension due to audit delay. [cite: 83] |
Detailed Analysis
The trading performance for the year ended 31 March 2025 surpassed management's expectations, driven by strong margin expansion in the second half. [cite: 86] [cite_start]Net debt was substantially reduced by £10.2m to £19.3m, showcasing improved financial resilience. [cite: 87]
The company's auditor, Forvis Mazars, requires additional time to complete procedures, causing a delay in the annual report. [cite: 81] [cite_start]Carclo has not been informed of any significant audit issues. [cite: 82] [cite_start]An audit tender process is currently underway. [cite: 85]
Further margin enhancement is anticipated as operational optimisation initiatives fully materialise. [cite: 88] [cite_start]A disciplined approach to cash management is expected to drive sustained financial resilience. [cite: 89] [cite_start]However, the expected share suspension from 1 August 2025 introduces significant near-term uncertainty for investors. [cite: 83]
Management has successfully executed on reducing debt and improving margins. The key failure is in the financial reporting timeline, which damages credibility despite the strong underlying performance. [cite_start]The commitment to restoring the usual reporting timetable is noted, but the damage is done for now. [cite: 84]
The positive news of a trading beat and significant debt reduction is completely negated by the amateurish delay in audited results and consequent share suspension. For a 'Speculative' profile stock, trust and timely reporting are paramount. The market is likely to view this as a major red flag, punishing the shares despite the underlying operational progress. The uncertainty created by the audit delay will overshadow any fundamental improvements until resolved.
Rank Group (RNK)
[cite_start]RNS Catalyst Assessment: A highly bullish trading update, with the company reporting full-year underlying operating profit will be ahead of market expectations, driven by strong trading momentum continuing into Q4. [cite: 630, 631]
Metric | Value | Commentary |
---|---|---|
LFL NGR Growth (FY) | +11% to c.£795m | [cite_start]Strong top-line growth across the group. [cite: 630] |
Underlying LFL Operating Profit | At least £63m | [cite_start]A significant beat versus prior expectations. [cite: 630] |
Key Driver | Continued Momentum | [cite_start]Strong trading in Q4 continued the positive trend from the first three quarters. [cite: 631] |
Detailed Analysis
The Group delivered a strong financial performance, with like-for-like Net Gaming Revenue (NGR) growing by 11% to approximately £795m for the full year. [cite: 630] [cite_start]Crucially, underlying operating profit is now guided to be at least £63m, surpassing consensus forecasts. [cite: 630]
The key operational highlight is the sustained trading momentum throughout the entire fiscal year, including a strong final quarter (Q4). [cite: 631] [cite_start]This demonstrates resilience and effective operational management despite facing significant cost and regulatory headwinds from the start of Q4. [cite: 631]
The outlook is very positive, described as an "exciting inflection point". [cite: 632] [cite_start]The catalyst is the land-based casino reforms coming into law on 22 July, which will allow the rollout of additional gaming machines across the Grosvenor estate. [cite: 632] This provides a clear, near-term driver for further growth.
Management has successfully navigated a challenging environment to deliver a profit beat. [cite_start]The Group is now poised to execute on the opportunities presented by deregulation, beginning the process of securing licence variations to enhance its casino offering. [cite: 632] This shows proactive and strategic forward planning.
This is a clear-cut positive catalyst. Rank has not only beaten profit expectations but has also provided a tangible near-term growth driver in the form of casino reforms. [cite_start]With the stock trading with an already high RSI of 69.4 and a 'High Flyer' PE of 17.1[cite: 646], this news is likely to be received extremely well, justifying the high valuation and potentially driving the share price higher, breaking through recent resistance. [cite_start]The 112% increase from the 250-day low shows strong momentum, which this news will amplify. [cite: 646]
Atalaya Mining (ATYM)
[cite_start]RNS Catalyst Assessment: A positive drilling update from Proyecto Masa Valverde (PMV), confirming and extending high-grade copper zones which are expected to be the initial focus for mine development. [cite: 1, 9]
Metric | Value | Commentary |
---|---|---|
Drill Result (MJ79) | 26m at 2.78% Cu | [cite_start]Includes a very high-grade intercept of 10m at 4.39% Cu. [cite: 7] |
Drill Result (MJ65) | 25m at 2.93% Cu | [cite_start]Another significant high-grade copper result. [cite: 3] |
Development Plan | Ramp development start | [cite_start]Expected to begin once surface rights purchase is completed. [cite: 10] |
Detailed Analysis
The announcement does not contain direct financial metrics but has significant positive financial implications. [cite_start]The high-grade copper zones de-risk the initial development phase of PMV and have the potential to deliver high-grade, profitable material to the existing Riotinto processing plant, enhancing future revenue streams. [cite: 11]
Multiple high-grade copper intercepts have been confirmed, with notable results like 25m at 2.93% Cu (MJ65) and 26m at 2.78% Cu (MJ79). [cite: 3, 7] [cite_start]Two rigs are currently active, focusing on infill and extensional drilling. [cite: 2] [cite_start]The stockwork-style mineralisation is expected to be amenable for processing at existing facilities, simplifying the operational plan. [cite: 8, 14]
The results support the company's plan for initial mine development focusing on these high-grade copper zones. [cite: 9] [cite_start]Infill drilling will continue for the remainder of 2025, which should lead to an updated Mineral Resource Estimate. [cite: 35] [cite_start]The CEO's comments express confidence in the potential to selectively mine and deliver high-grade material. [cite: 11]
Atalaya is executing its strategy of developing satellite deposits in a capital-efficient manner by leveraging its existing 15 Mtpa processing plant at Proyecto Riotinto. [cite: 11] [cite_start]The planned ramp development, subject to land purchases and board approval, is the next logical step in bringing PMV online and creating a central processing hub. [cite: 10, 27]
These are strong drilling results that materially de-risk the initial development of the Masa Valverde project. For a mining company, exploration success is a primary value driver. The confirmation of high-grade, easily processable copper should be well-received, supporting the project's economics. [cite_start]With a 'Value Stock' profile (PE of 12) [cite: 646] [cite_start]and the price already up 53.3% from its 250-day low[cite: 646], these results provide fundamental backing for the recent share price strength and could attract further investment as the project moves towards development.
Griffin Mining Ltd. (GFM)
RNS Catalyst Assessment: SEARCH_COMPLETE_NO_MATCH_FOUND: The entity 'Griffin Mining Ltd. (GFM)' was not located in the provided source document.
No RNS announcement for Griffin Mining Ltd. (GFM) was found in the provided text file. Analysis cannot proceed.
CML Microsystems (CML)
[cite_start]RNS Catalyst Assessment: A highly significant and bullish contract win, securing a 12-year design and supply agreement valued at over $30 million with a leading manufacturer of industrial GNSS equipment. [cite: 580]
Metric | Value | Commentary |
---|---|---|
Contract Value | > $30 million | [cite_start]Represents a substantial portion of CML's £44.6m market cap. [cite: 580, 646] |
Contract Duration | 12 years | [cite_start]Provides exceptional long-term revenue visibility and stability. [cite: 580] |
Market | Global Satellite (GNSS) | [cite_start]Strengthens CML's strategic position in a high-growth market. [cite: 581] |
Detailed Analysis
This contract is transformative from a financial perspective. [cite_start]At over $30m, it underpins a significant portion of future revenues for a company with a market cap of only £44.6m. [cite: 580, 646] This provides a high degree of certainty to future earnings, which is rare for a small-cap tech company.
The deal includes both advanced design services and product supply, showcasing CML's end-to-end capabilities. [cite: 580] [cite_start]The agreement highlights the strength of its in-house production test capabilities in the UK and Silicon Valley, which are critical for meeting stringent industry requirements. [cite: 582]
The outlook is substantially de-risked. [cite_start]The 12-year term provides unparalleled visibility. [cite: 580] The market should re-rate the stock based on this secured revenue stream. [cite_start]The current 'Speculative' tag, based on zero forecast PE[cite: 646], is now likely outdated as this contract will flow through to future earnings estimates.
This is a major strategic victory, reinforcing CML's commitment to the global satellite technology market. [cite: 581] [cite_start]It demonstrates the success of their focus on high-growth, high-barrier-to-entry sub-segments and their ability to secure long-term partnerships with blue-chip customers. [cite: 587, 588]
This is a game-changing contract for CML Microsystems. A $30m+ deal is extremely material relative to its £44.6m market cap. The 12-year term provides exceptional revenue visibility, which should command a significant valuation premium. [cite_start]The stock has a 'Speculative' profile due to a lack of current earnings forecasts[cite: 646], but this announcement makes a strong case for a fundamental re-rating. [cite_start]Despite the shares being up 33.3% from their 250-day low[cite: 646], this news provides a powerful justification for a significant move higher as the market digests the long-term financial impact.
Hostelworld Group (HSW)
[cite_start]RNS Catalyst Assessment: A broadly positive trading update, reiterating full-year guidance and highlighting encouraging June trends, a share buyback, and the reinstatement of a progressive dividend, which collectively outweigh flat H1 revenue and bookings. [cite: 637, 638, 636]
Metric | Value | Commentary |
---|---|---|
H1 Net Revenue | €46.7m (0% YoY) | [cite_start]Flat performance in the first half. [cite: 633] |
H1 Adjusted EBITDA | €7.4m | [cite_start]Down from €9.6m in H1'24, impacted by higher marketing spend. [cite: 634] |
Capital Returns | Dividend & Buyback | [cite_start]Progressive dividend policy reinstated and £5m buyback underway. [cite: 637, 636] |
Detailed Analysis
H1 performance was mixed, with flat net revenue at €46.7m and a decrease in adjusted EBITDA to €7.4m from €9.6m year-on-year, attributed to higher direct marketing costs. [cite: 633, 634] [cite_start]However, the company has reiterated FY25 EBITDA guidance in line with consensus, suggesting a stronger H2 is expected. [cite: 638] [cite_start]Net cash position is solid at €6.1m. [cite: 635]
Encouragingly, June saw booking volume and ABV growth across all key regions. [cite: 633] [cite_start]Strategic initiatives are showing progress: bookings via mobile apps grew 11% YoY, and the new 'Elevate' tool is increasing base commissions. [cite: 640] [cite_start]The proportion of bookings from social members has risen to 85%. [cite: 642]
The outlook for the full year remains intact, which is a key positive. [cite: 638] [cite_start]Management notes an improving geographic mix and a pickup in European demand. [cite: 639] [cite_start]The most significant growth initiatives are scheduled for late 2025 and early 2026, setting the stage for future growth beyond the current year. [cite: 644]
Management is executing a balanced capital allocation strategy. [cite_start]While investing in marketing and growth initiatives, the company is also returning capital to shareholders via a newly announced £5m share buyback and the reinstatement of a progressive dividend policy. [cite: 636, 637] This signals strong confidence in the future cash generation of the business.
While the headline H1 numbers are uninspiring, the market is likely to focus on the forward-looking positives: reaffirmed guidance, positive June trading momentum, and confident capital return policies. [cite_start]The reinstatement of the dividend and the active share buyback are powerful signals of the board's belief in the 'Value Stock' characteristics of the company (PE 13.5)[cite: 647]. [cite_start]The stock has strong momentum, up 32.9% from its low[cite: 647], and this news provides fundamental support for a continued positive trajectory as investors are rewarded for their patience.
The Pebble Group (PEBB)
[cite_start]RNS Catalyst Assessment: A neutral and reassuring trading update, confirming that performance is in line with expectations and announcing a tender offer to return further capital to shareholders. [cite: 531, 540]
Metric | Value | Commentary |
---|---|---|
HY 25 Trading | In line with expectations | [cite_start]Reassuring performance despite some currency and macro headwinds. [cite: 531] |
Tender Offer | Up to £6.5m | [cite_start]Accelerated return of capital to shareholders, launching 21 July. [cite: 540] |
Net Cash (30 Jun 25) | £6.0m | [cite_start]Solid cash position despite £2.6m of distributions in H1. [cite: 538] |
Detailed Analysis
The Group's HY 25 Revenue and Adjusted EBITDA are in line with management expectations, a solid result considering USD:GBP currency headwinds. [cite: 531] [cite_start]Facilisgroup revenue is broadly flat YoY in USD, while Brand Addition revenue is down c.4%. [cite: 533, 536] [cite_start]Critically, the full-year forecast remains on track. [cite: 532]
Momentum in new partner wins at Facilisgroup is improving, and total order values for H2 at Brand Addition are showing improvement on the prior year. [cite: 534, 537] [cite_start]Operating cash conversion is improving as planned and is expected to be above 80% for the full year, a significant improvement from 68.2% in FY 24. [cite: 537]
While cautious about the broader macro economy, management believes trading supports the delivery of FY 25 market expectations. [cite: 541] [cite_start]Confidence in the Group's businesses to capitalise on opportunities and deliver sustainable earnings growth is stated. [cite: 543] [cite_start]The tender offer provides a direct return to shareholders. [cite: 540]
The Group is demonstrating strong capital discipline, evidenced by the improving cash conversion and healthy net cash position. [cite: 537, 538] [cite_start]The decision to launch a tender offer, following the completion of a share buyback, shows a clear commitment to returning excess capital to shareholders while continuing to invest in organic growth. [cite: 539, 540]
This is a classic 'steady as she goes' update, which is no bad thing in the current environment. Confirming that full-year expectations are intact provides a solid floor for the share price. The main catalyst here is the £6.5m tender offer, which provides a tangible cash return and demonstrates management's confidence in future cash flows. [cite_start]For a 'Value Stock' (PE 12.8, fc EPS growth 0%)[cite: 646], such capital returns are a key part of the investment case. The market should react calmly, with the tender offer providing support against a backdrop of macro uncertainty.
Johnson Service Group (JSG)
[cite_start]RNS Catalyst Assessment: A neutral trading update confirming progress towards margin targets and revenue growth, but noting unpredictable consumer spend and a slower-than-anticipated start to the summer for its HORECA division. [cite: 181, 187, 182]
Metric | Value | Commentary |
---|---|---|
H1 Group Revenue | £257.6m (+5.5%) | [cite_start]Solid top-line growth, primarily from the HORECA division. [cite: 179] |
Organic Revenue Growth | +1.4% | [cite_start]Modest underlying growth, indicating reliance on acquisitions. [cite: 180] |
Margin Target | On track for >14% by 2026 | [cite_start]Reassurance that the key medium-term target remains achievable. [cite: 181] |
Detailed Analysis
Group revenue for H1 increased by a solid 5.5% to £257.6m. [cite: 179] [cite_start]However, organic growth was a more muted 1.4%, highlighting the impact of acquisitions. [cite: 180] [cite_start]The company is pleased with the margin achieved in H1 and remains on track for its 2026 target of at least 14.0%. [cite: 181] [cite_start]Bank debt stands at c.£99.0m, impacted by an ongoing share buyback. [cite: 184]
The HORECA (Hotels, Restaurants, Catering) division experienced a slower than anticipated start to the summer, though volumes have seen a slight improvement recently. [cite: 182] [cite_start]Workwear volumes have been stable, with strong new installations and positive retention rates. [cite: 182] [cite_start]Operating costs are being closely managed across the Group. [cite: 183]
The board is confident that 2025 will be another year of progress in revenue and margin growth. [cite: 187] [cite_start]However, it strikes a cautious tone on consumer discretionary spending, noting it "remains unpredictable". [cite: 182] [cite_start]The company also confirmed its intention to move from AIM to the Main Market, with admission expected on 1 August 2025. [cite: 189]
JSG is executing its strategy of growth and margin enhancement, supported by acquisitions. [cite_start]The ongoing £30m share buyback programme demonstrates confidence and a commitment to shareholder returns. [cite: 185] [cite_start]The move to the Main Market is a significant strategic step, aimed at increasing the company's profile and attracting a wider investor base. [cite: 189]
This is a reassuringly steady, if unexciting, update. The confirmation of being on track for margin targets and the planned move to the Main Market are structural positives. However, the cautious commentary on the core HORECA division's summer trading will temper enthusiasm. [cite_start]With a 'Value Stock' profile (PE 12.8) but strong forecast EPS growth of 29.5%[cite: 646], the market will likely adopt a 'wait and see' approach, looking for concrete evidence of improving HORECA volumes before re-rating the stock. The news is unlikely to cause a significant share price move in either direction.
Macfarlane Group (MACF)
RNS Catalyst Assessment: A significant profit warning and clear negative catalyst. [cite_start]The company now expects full-year adjusted operating profit to be approximately 10% below 2024 levels, citing weaker demand, margin pressure, and rising costs. [cite: 94]
Metric | Value | Commentary |
---|---|---|
FY 2025 Profit Guidance | ~10% below 2024 | [cite_start]A clear and quantified profit warning. [cite: 94] |
Distribution Division | Weaker than expected demand | [cite_start]Core division is underperforming. [cite: 94] |
Manufacturing Operations | Performing robustly | [cite_start]A key positive offset, but not enough to counter distribution weakness. [cite: 95] |
Detailed Analysis
The headline is a reduction in full-year expectations, with adjusted operating profit guided to be c.10% below 2024. [cite: 94] [cite_start]This is attributed to a confluence of negative factors: weaker demand, margin pressure from competition, rising input prices, and slow recovery of cost increases. [cite: 94]
Performance is bifurcated. [cite_start]The Distribution business is struggling with demand and delays in new business decisions. [cite: 94] [cite_start]In contrast, Manufacturing Operations are performing robustly, with good momentum from aerospace and defence customers and benefits from the Polyformes acquisition. [cite: 95]
The Chair's statement notes it is "disappointing that the momentum increase we experienced early in Q2 2025 has not been maintained". [cite: 100] [cite_start]The focus for the rest of 2025 is on mitigating actions: cost recovery, further cost-saving actions, and converting a strong new business pipeline. [cite: 97]
Management is reacting to the downturn with an action plan. [cite_start]The continuation of the share buyback programme is a small sign of confidence, and net bank debt remains well within facilities, so there is no immediate balance sheet stress. [cite: 99, 98] [cite_start]The Board remains confident in the longer-term prospects. [cite: 101]
Macfarlane's profit warning is a significant blow, crystallising the challenging conditions previously flagged. The market will likely react harshly to the quantified ~10% profit downgrade. [cite_start]Despite the stock's 'Value Stock' profile with a low PE of 9.6 and modest broker upside[cite: 646], a profit warning often triggers a sharp de-rating that overshoots fundamentals. [cite_start]The fact the stock is only 10.7% from its 250-day high suggests investors were not positioned for this severity of news, increasing the potential for a sharp negative reaction. [cite: 646]
DP Poland (DPP)
[cite_start]RNS Catalyst Assessment: A broadly neutral trading update showing a significant sales turnaround in May and June after a weak April, but with underlying order volumes remaining negative. [cite: 600]
Metric | Value | Commentary |
---|---|---|
Poland H1 System Sales | +4.9% YoY | [cite_start]A positive result driven by a strong turnaround in May/June. [cite: 600] |
Poland H1 LFL System Orders | -7.0% YoY | [cite_start]Concerning drop in underlying order volumes. [cite: 604] |
Croatia H1 System Sales | +7.0% YoY | [cite_start]Solid growth maintained in the smaller Croatian market. [cite: 600] |
Detailed Analysis
The financial picture is mixed. [cite_start]In Poland, total system sales for H1 grew 4.9%, a positive headline figure thanks to record sales in May and June which reversed a weak start to Q2. [cite: 600] [cite_start]However, Like-for-Like (LFL) system orders fell by a worrying 7.0% in H1, suggesting growth is being driven by price increases or new stores, not underlying volume. [cite: 604]
The acquisition and initial integration of Pizzeria 105 is a key milestone. [cite: 601] [cite_start]Early franchisee feedback is positive, and pilot store conversions to the Domino's brand are imminent. [cite: 601, 613] [cite_start]The company is advancing its sell-down of corporate stores, franchising five in H1 to new partners. [cite: 617]
The CEO looks forward to an "exciting second half". [cite: 604] [cite_start]The growth strategy is now primarily focused on store network expansion, led by the Pizzeria 105 conversions, rather than strong LFL growth. [cite: 609, 610] [cite_start]This pivot to a capital-light, franchisee-led model is expected to drive scalability and improve profitability. [cite: 611]
The company is clearly executing its strategy to become the market leader in Poland. [cite: 603] [cite_start]The Pizzeria 105 acquisition accelerates this plan significantly. [cite: 612] [cite_start]The focus is on quality, value, and innovation to drive customer acquisition, while the franchising model is intended to deliver a leaner corporate structure. [cite: 602, 611]
The market will likely be torn on this update. [cite_start]While the H1 sales growth and strong finish to the quarter are encouraging, the 7% drop in like-for-like orders in the core Polish market is a significant concern that cannot be ignored. [cite: 604] [cite_start]The narrative is shifting from organic growth to acquisitive, franchise-led expansion via Pizzeria 105. For a 'Speculative' stock[cite: 646], execution on this integration is now the single most important factor. The update is likely to be a neutral event until there is clear evidence that the new strategy is successfully translating into profitable growth.
Polar Capital Holdings (POLR)
[cite_start]RNS Catalyst Assessment: A negative update for the quarter, with continued net outflows of £0.6bn, primarily from the flagship Technology fund, which overshadows the AuM increase driven by market performance. [cite: 497, 501]
Metric | Value | Commentary |
---|---|---|
AuM (30 Jun 25) | £23.2bn | [cite_start]Up 8% in the quarter, but driven entirely by market movement. [cite: 496, 497] |
Net Flows (Qtr) | -£0.6bn | [cite_start]Significant outflows continue to plague the group. [cite: 497] |
Technology Fund Outflows | -£162m | [cite_start]While an improvement on the previous quarter's £200m, this is still a major drain. [cite: 503] |
Detailed Analysis
Assets under Management (AuM) rose 8% in the quarter to £23.2bn. [cite: 496] However, this headline figure masks underlying weakness. [cite_start]The increase was solely due to £2.7bn in positive market performance, which was offset by £0.6bn in net outflows and a £0.3bn return of capital from a trust. [cite: 497]
There is a clear divergence in fund flows. [cite_start]While there was continued demand for a broad range of smaller funds (AI, Asian Stars, etc.), with combined net inflows of £124m, this was swamped by outflows from larger strategies. [cite: 500] [cite_start]The open-ended Technology fund saw net outflows of £162m, and there were further significant outflows from an institutional Healthcare mandate and an Emerging Markets client. [cite: 503]
The CEO remains confident in the long-term, citing significant fund capacity and improving relative performance. [cite: 504] However, the persistent outflows, particularly from the key Technology fund, will be the market's primary focus. [cite_start]The new business pipeline for the Emerging Markets and Asia team is described as strong, but this needs to convert to stem the tide. [cite: 503]
The company is successfully managing its diverse range of specialist funds, with some attracting assets. [cite: 500] [cite_start]The successful conclusion of the Global Financials Trust tender offer shows competent corporate action management. [cite: 501] However, the core strategic challenge remains stopping the bleed from its largest and most well-known funds.
Despite the positive market-driven AuM growth, the market will fixate on the £0.6bn of net outflows. For an asset manager, flows are the key health metric. The continued bleeding from the flagship Technology fund is a major concern. [cite_start]The stock has a 'Value Stock' profile with a PE of 11.5, but the high RSI of 69.9 suggests it is technically overbought and vulnerable to negative news. [cite: 646] This update provides that negative catalyst, and the stock is likely to trade down as the market questions when the outflow trend will finally reverse.
Severn Trent (SVT)
[cite_start]RNS Catalyst Assessment: A solid, in-line trading update demonstrating strong operational performance and capital investment, confirming the company is on track to meet financial guidance for the year. [cite: 55, 57]
Metric | Value | Commentary |
---|---|---|
Performance vs Guidance | In line with expectations | [cite_start]No surprises, which is a positive for a utility. [cite: 55] |
ODI Reward (FY26) | At least £25m | [cite_start]On track to deliver outperformance rewards. [cite: 55] |
Q1 Capex | ~£360m (+19% YoY) | [cite_start]Significant investment in the network is underway. [cite: 57] |
Detailed Analysis
The company confirms its financial performance for the year remains on track and in line with guidance. [cite: 55] [cite_start]It expects to deliver at least £25m in Outcome Delivery Incentives (ODI) reward in FY26, signaling operational outperformance is translating into financial gains. [cite: 55]
Significant operational improvements are being delivered, particularly in leakage reduction and bringing down storm overflow spills. [cite: 55] [cite_start]Over 2,000 storm overflow interventions have led to a 65% reduction in spills compared to the same period last year, putting the company on track to hit its annual target. [cite: 56]
The outlook is stable, with the company on track to deliver between £1.7bn and £1.9bn of capital expenditure in FY26. [cite: 57] The announcement is a statement of steady progress, consistent with the expectations for a large-cap utility stock.
The company is successfully executing its Asset Management Plan (AMP8), with a 19% year-on-year increase in capital investment in Q1 to around £360m. [cite: 57] This demonstrates a clear commitment to investing in its network to meet regulatory requirements and improve service.
For a utility giant like Severn Trent, an 'in-line' statement is a positive event, removing any uncertainty. The confirmation of achieving at least £25m in ODI rewards is a tangible sign of operational excellence. [cite_start]The stock fits a 'Value Trap' profile (PE 15.9, EPS growth 41.3%)[cite: 646], but its defensive nature and reliable dividend are the main attractions. This update reinforces those qualities. [cite_start]Given the stock is only 4.62% off its 250-day high[cite: 646], the market is likely to take this news calmly, with little share price impact expected.
Central Asia Metals (CAML)
[cite_start]RNS Catalyst Assessment: A negative operations update, with the company cutting its full-year production guidance for both zinc and lead at its Sasa mine due to challenges with orebody geometry and head grades. [cite: 156, 157]
Metric | Value | Commentary |
---|---|---|
FY25 Zinc Guidance | Revised to 17-19k tonnes | [cite_start]A cut from previous, unstated guidance. [cite: 153] |
FY25 Lead Guidance | Revised to 25-27k tonnes | [cite_start]A cut from previous, unstated guidance. [cite: 153] |
Kounrad Copper Production | In line with guidance | [cite_start]The one stable element of the report, but overshadowed by Sasa. [cite: 155] |
Detailed Analysis
The guidance cut for Sasa's zinc and lead production will have a direct negative impact on FY2025 revenue and profitability. [cite: 153] [cite_start]While copper production at Kounrad remains on track, the Sasa mine is a significant contributor to the group's earnings, making this revision material. [cite: 155] [cite_start]Net cash at 30 June 2025 was a healthy $42.9 million. [cite: 153]
Operationally, the key issue is at the Sasa mine, where maintaining head grades has been challenging due to orebody variability as mining goes deeper. [cite: 156] [cite_start]This was anticipated, but the impact is clearly more severe than expected. [cite: 156] [cite_start]On a positive note, the new Dry Stack Tailings plant is operational, and the transition to paste-fill mining continues, which are important long-term environmental and operational improvements. [cite: 153]
The outlook for Sasa is now weaker for H2 2025, although management expects head grades to improve as new mining methods increase. [cite: 157] [cite_start]The decision to revise guidance is described as "prudent". [cite: 157] [cite_start]The Kounrad copper guidance is reiterated at 13,000 to 14,000 tonnes. [cite: 153] [cite_start]The ongoing takeover offer for New World Resources adds a layer of corporate activity to the outlook. [cite: 172]
The company is executing on its major capital projects at Sasa (DST plant) and pursuing growth through exploration (Aberdeen Minerals, CAML X) and M&A (New World Resources). [cite: 153, 164, 166, 172] However, the operational challenges at Sasa highlight the inherent risks in mining and the difficulty in perfectly forecasting geological conditions.
A production guidance cut is a clear negative for any miner. While the issues at Sasa were flagged as a risk, this revision makes the problem tangible and will lead to reduced earnings forecasts. The stock's 'Value Stock' profile (PE of 8.8) offers some cushion, but the market dislikes operational disappointments. [cite_start]With the stock trading 22% below its 250-day high and an RSI of 50.2[cite: 646], it isn't in clear oversold territory, suggesting there is room for a further move down on this news as the market prices in the lower production profile.
Trifast (TRI)
[cite_start]RNS Catalyst Assessment: A strong set of full-year results, with profit performance ahead of market expectations, driven by significant margin recovery and a strengthening balance sheet despite revenue headwinds. [cite: 269, 271, 275]
Metric | Value | Commentary |
---|---|---|
Underlying EBIT (CER) | £15.6m (+30.3%) | [cite_start]Significant growth, beating consensus of £14.6m. [cite: 271, 296] |
EBIT Margin (CER) | 6.8% (+173bps) | [cite_start]Successful execution of strategic initiatives driving profitability. [cite: 271] |
Adjusted Net Debt / EBITDA | 0.97x | [cite_start]Strengthened balance sheet, down from 1.30x in FY24. [cite: 275] |
Detailed Analysis
Trifast delivered a strong beat, with underlying EBIT of £15.6m (CER) ahead of the £14.6m consensus. [cite: 271, 296] [cite_start]This was achieved despite a 2.7% (CER) fall in revenue, demonstrating powerful operational gearing and margin expansion. [cite: 270, 271] [cite_start]Gross margin improved by 300bps. [cite: 302] [cite_start]Underlying PBT grew significantly to £11.0m (CER). [cite: 273] [cite_start]The dividend was maintained at 1.80p. [cite: 277]
The performance was driven by the successful first stage of the 'Recover, Rebuild, Resilience' transformation strategy. [cite: 278] [cite_start]The company achieved c.£3.0m in cost savings and made good progress across all four strategic initiatives: margin management, focused growth, operational efficiency, and organisational effectiveness. [cite: 272, 279]
The company notes that trading headwinds (macro pressures, auto softness, US tariffs) have persisted into Q1 FY26. [cite: 287, 288] [cite_start]However, it expresses confidence that its self-help levers can offset these and keep it on track to achieve its medium-term target of an EBIT margin >10%. [cite: 293] The focus remains on driving internal improvements.
Management has clearly delivered on the 'Recover' phase of its strategy. [cite: 352] [cite_start]The significant improvements in margin, ROCE (up to 8.1% from 5.7%), and balance sheet strength in a tough revenue environment are testament to successful execution of its self-help programme. [cite: 276, 275] [cite_start]The business is now leaner and more resilient entering the 'Rebuild' phase. [cite: 366, 380]
This is a very strong result. Beating profit expectations through margin enhancement and cost control during a period of falling sales is a significant achievement and demonstrates management credibility. While the cautious Q1 outlook might temper the initial rally, the market should reward the impressive execution of the turnaround plan. [cite_start]The stock fits a 'Value Stock' profile (PE 11.7) but with a deeply negative EPS forecast (-68.6%)[cite: 648], which these results challenge. The market will likely re-evaluate that forecast upwards, seeing the self-help story as a powerful counter to macro headwinds, potentially leading to a sustained re-rating.
Vistry Group (VTY)
[cite_start]RNS Catalyst Assessment: A mixed trading update where H1 profits are in line with expectations and net debt is better than forecast, but this is set against a backdrop of lower completions, reduced sales rates, and a significant drop in revenue. [cite: 115, 118, 121]
Metric | Value | Commentary |
---|---|---|
H1 Adjusted PBT | c.£80m (vs £120.7m H1 24) | [cite_start]In line with expectations, but a significant YoY decline. [cite: 115] |
H1 Completions | c.6,800 (vs 7,792 H1 24) | [cite_start]A notable slowdown in delivery volumes. [cite: 118] |
Net Debt (30 Jun 25) | c.£295m (better than expected) | [cite_start]A key positive, showing good cash management. [cite: 115, 139] |
Detailed Analysis
First-half profits are in line with expectations, but show a steep decline year-on-year, with adjusted PBT at c.£80m versus a restated £120.7m in H1 2024. [cite: 115] [cite_start]Revenue is expected to be c.£1.8bn, down from £2.0bn. [cite: 121] [cite_start]The key positive is the net debt position of c.£295m, which is significantly better than forecast and lower than the prior year. [cite: 139]
Completions were down at c.6,800 (from 7,792), and the sales rate slowed to 1.02 from 1.21. [cite: 118, 119] [cite_start]Demand from affordable housing partners was lower due to funding uncertainty, while PRS demand was resilient. [cite: 122, 124] [cite_start]Open Market demand suffered from affordability challenges. [cite: 125] [cite_start]The company successfully refinanced its debt facilities out to 2028. [cite: 142]
The Group remains on track to deliver a year-on-year increase in profits for the full year (FY25), supported by a strong forward order book of £4.3bn. [cite: 115, 147] [cite_start]A significant catalyst is the government's new £39bn Affordable Homes Programme, which is expected to drive a step-up in volumes in H2 2025 and beyond. [cite: 113, 114]
Vistry's Partnerships strategy is perfectly aligned with the new government funding programme, positioning it as a key delivery partner. [cite: 113, 135] [cite_start]The company is managing build cost inflation effectively and has made good progress with embedding standardised processes across the business. [cite: 126, 130] [cite_start]The share buyback programme is also continuing. [cite: 141]
While meeting H1 profit expectations is reassuring, the underlying metrics of falling completions, sales rates, and revenue paint a challenging picture. The market will likely weigh this current weakness against the huge future potential offered by the government's Affordable Homes Programme. [cite_start]Given the 'Value Stock' profile (PE 10.8), high short interest of 2.82%, and a deeply negative forecast EPS growth of -34.8%[cite: 648], investors are clearly sceptical. This update, with its confirmation of H1 weakness, may embolden bears, despite the positive long-term funding backdrop and strong debt management.
Liontrust Asset Management (LIO)
[cite_start]RNS Catalyst Assessment: A clearly negative trading update, revealing an acceleration in net outflows to £1.1 billion for the quarter, indicating continued pressure on the business despite claims of a more positive environment for active management. [cite: 505, 507]
Metric | Value | Commentary |
---|---|---|
Net Flows (Qtr) | -£1.1 billion | [cite_start]A significant increase in outflows compared to £0.9bn in the prior year period. [cite: 505] |
AuMA (30 Jun 25) | £22.6 billion | [cite_start]Unchanged over the quarter, as market performance offset the large outflows. [cite: 506] |
Long-term Performance | 73% of funds 1st/2nd quartile | [cite_start]A key positive management is highlighting, but not stopping current outflows. [cite: 508] |
Detailed Analysis
The key financial metric is the net outflow of £1.1bn. [cite: 505] [cite_start]This represents nearly 5% of the opening Assets under Management and Advice (AuMA) being withdrawn in a single quarter. [cite: 511] [cite_start]While market and investment performance of +£1.1bn coincidentally cancelled this out, leaving AuMA flat at £22.6bn, the underlying trend is starkly negative. [cite: 506, 511]
The company highlights its strong long-term fund performance, with 73% of funds in the top two quartiles since inception. [cite: 508] This demonstrates underlying product quality. [cite_start]However, short-term performance is clearly not compelling enough to retain assets, with UK Retail Funds & MPS bearing the brunt of the outflows (£1.2bn). [cite: 511]
CEO John Ions speaks of a more positive environment for active management, but the numbers in this update contradict that optimism for Liontrust specifically. [cite: 507] Until the flow data turns positive, the outlook will be viewed with scepticism by the market.
The company states it is making progress on its strategic objectives of broadening distribution. [cite: 509] [cite_start]The positive net flows into International Funds & Accounts (+£135m) provide a small glimmer of hope that this strategy is gaining some traction, but it is far too small to offset the retail bleed. [cite: 511]
This is a poor update that will be badly received. In the asset management business, flows are everything. An acceleration in net outflows to £1.1bn is a significant negative signal that overshadows any commentary about long-term performance. [cite_start]The stock has a 'Value Stock' profile (PE 8.2) but is trading 46% below its 250-day high, reflecting deep investor pessimism. [cite: 648] This update validates that bearishness. The stock is likely to test its recent lows as the market questions the strategy to halt the significant asset bleed.
PageGroup (PAGE)
[cite_start]RNS Catalyst Assessment: A decidedly negative Q2 trading update, showing a resilient but deteriorating performance with a worsening in Continental Europe and a significant reduction in headcount, pointing to a tough outlook. [cite: 205, 211, 222]
Metric | Value | Commentary |
---|---|---|
Q2 Group Gross Profit | -10.5% (constant currency) | [cite_start]An acceleration of the decline from -9.2% in Q1. [cite: 204] |
Fee Earner Headcount | -133 (-2.5%) in Q2 | [cite_start]Significant reduction, signaling management expects continued weakness. [cite: 207] |
Germany Gross Profit | -21% | [cite_start]Particularly tough conditions in a key European market. [cite: 226] |
Detailed Analysis
Group gross profit declined 10.5% in constant currencies in Q2, a deterioration from the 9.2% decline in Q1. [cite: 204] [cite_start]Performance was mixed, with a worsening in EMEA (-17.1%) and the UK (-14.3%), but improvement in Asia (+0.6%) and growth in the Americas (+2.9%). [cite: 204] [cite_start]Permanent recruitment (-11.3%) was hit harder than temporary (-8.2%). [cite: 221]
The most significant operational point is the reduction in fee earner headcount by 133 in the quarter, mainly in Europe. [cite: 222] [cite_start]This cost-cutting measure reflects the subdued levels of client and candidate confidence, which impacted decision-making and extended time-to-hire. [cite: 206] [cite_start]Productivity per fee earner declined by 3%. [cite: 208]
The Board expects 2025 operating profit to be broadly in line with the current market consensus of c.£22m. [cite: 210] While this is a reassurance against a further downgrade, it represents a massive drop from historic levels. [cite_start]The outlook remains uncertain due to the unpredictable economic environment. [cite: 215]
Management is actively managing the cost base, evidenced by the headcount reductions. [cite: 208] [cite_start]The company continues to invest in technology, such as Customer Connect and Page Insights, to support productivity. [cite: 214] [cite_start]The strategy is focused on balancing near-term productivity with long-term positioning for a market recovery. [cite: 213]
The accelerating decline in gross profit and, more importantly, the significant cut in fee-earner headcount, sends a clear signal that management sees no near-term recovery. This is a business with high operational gearing, and the current environment is brutal. [cite_start]The 'High Flyer' profile (PE 52.2) is completely at odds with the deeply negative forecast EPS growth (-63%). [cite: 648] [cite_start]The stock is already down 37.9% from its high[cite: 648], reflecting this pain, but today's confirmation of worsening trends, particularly in Europe, could lead to further downside as the market digests the tough road ahead.
Creo Medical Group (CREO)
[cite_start]RNS Catalyst Assessment: A positive, though early-stage, clinical development update, announcing the first patient has been treated in a new post-market study for its MicroBlate™ Flex device for lung tumours. [cite: 545]
Metric | Value | Commentary |
---|---|---|
Event | First Patient Treated | [cite_start]Initiation of a new landmark clinical study. [cite: 545] |
Device | MicroBlate™ Flex | [cite_start]Device for soft tissue ablation, targeting lung tumours. [cite: 550] |
Collaboration | Intuitive Surgical | [cite_start]Study complements programme with Intuitive's Ion system. [cite: 549] |
Detailed Analysis
There are no direct financial implications in this announcement. This is a pre-commercialisation company, and value is driven by progress through the clinical and regulatory pathway. [cite_start]This study is a crucial step in generating the data required for eventual commercialisation. [cite: 549]
The initiation of this "ablate and resect" study is a significant operational milestone. [cite: 545] [cite_start]This study design, where the ablated tumour is surgically removed and analysed, provides a vital and robust measure of the device's performance. [cite: 546] [cite_start]The study is taking place at prestigious institutions in the Netherlands and the UK. [cite: 547]
The outlook for MicroBlate™ Flex is enhanced by this news. [cite_start]The data generated, along with data from another post-market study and the collaboration with Intuitive, will create a substantial clinical dataset. [cite: 549] This is a critical prerequisite for commercialisation and adoption by clinicians.
Creo is methodically executing its clinical strategy to build a robust body of evidence for its core technology. [cite_start]The multi-pronged approach (direct studies, collaboration with Intuitive) is smart, building a comprehensive case for the device's efficacy and safety in the huge potential market of lung cancer treatment. [cite: 549, 554]
For a pre-revenue med-tech company like Creo, progress in clinical trials is the primary value driver. Initiating this study is a necessary and positive step. However, the market impact will be muted as it's an early milestone with no immediate revenue attached. [cite_start]The stock has a 'Speculative' profile and is down over 60% from its 250-day high, with an RSI of 38.6 indicating it is approaching oversold territory. [cite: 648] This news provides a flicker of fundamental progress but is unlikely to trigger a major re-rating until tangible data from the study is released.
Pantheon Resources (PANR)
[cite_start]RNS Catalyst Assessment: A neutral to slightly positive operational update, confirming the mobilisation of a rig for the Dubhe-1 appraisal well, which is a key step in progressing the Ahpun Topset development. [cite: 557]
Metric | Value | Commentary |
---|---|---|
Event | Rig Mobilisation | [cite_start]The Nabors 105AC rig is contracted and moving to the drill site. [cite: 557] |
Primary Target | Ahpun Topsets | [cite_start]Targeting 2C Contingent Resources of 282 million barrels of liquids. [cite: 557] |
Upside Potential | 3 additional zones | [cite_start]Well will penetrate three exploration targets not included in resource estimates. [cite: 558, 562] |
Detailed Analysis
The announcement confirms the admission of 95.8m new shares following a recent fundraise, an essential step to fund this drilling activity. [cite: 565] [cite_start]The well is targeting a resource with a CG&A estimated NPV10 of $1.7 billion, highlighting the significant value potential at stake. [cite: 557]
The key operational milestone is the contracting and mobilisation of the Nabors 105AC rig to the Dubhe-1 pad. [cite: 557] This marks the formal start of the next phase of appraisal drilling. [cite_start]The well plans for a potential lateral completion and long-term flow test to prove deliverability. [cite: 558]
The Dubhe-1 well is set to generate significant news flow over the coming months. [cite: 559] Success has the potential to support resource and valuation upgrades. [cite_start]Key potential upsides include a thicker-than-expected target zone and the penetration of three additional exploration targets not currently in the resource estimates. [cite: 560, 562]
Pantheon is executing its strategy to appraise and de-risk its vast resource base on the Alaskan North Slope. [cite_start]This well is a critical step towards progressing the Ahpun field to a Final Investment Decision (FID) and demonstrating the commerciality of the project. [cite: 572] The company is delivering on its stated operational plans following its recent fundraising.
This update is an operational necessity and confirmation that the company is putting its newly raised funds to work. While rig mobilisation is not a value catalyst in itself, it fires the starting gun on a period of high-impact news flow. For a 'Speculative' oil & gas explorer, drilling results are everything. [cite_start]The stock is down nearly 70% from its 250-day high, reflecting past disappointments and funding challenges. [cite: 648] [cite_start]With an RSI of 34.6, it is close to oversold. [cite: 648] This announcement will be neutral today, but it puts Pantheon firmly on the watchlist pending drilling results, which have the potential to trigger a major re-rating if successful.
Strix Group (KETL)
RNS Catalyst Assessment: This is a P2 announcement (AGM Statement). It primarily reviews previously announced results and confirms the initiation of a refinancing process. [cite_start]The key new information is the board appointment of Rachel Pallett as Chief Commercial Officer. [cite: 592, 593, 594]
As an AGM statement, this contains little new information to move the share price. [cite_start]The confirmation of initiating a refinancing process is a necessary step to support growth but also introduces a period of uncertainty until the terms are known. [cite: 593] [cite_start]The appointment of Rachel Pallett, with her extensive experience at Spirax and Renishaw, is a high-quality addition to the board and a long-term positive. [cite: 595, 596] [cite_start]For a stock with a 'Value Trap' profile (PE 6.1, EPS growth -28.9%) that is down 53.5% from its high[cite: 648], the market is looking for a fundamental turnaround catalyst. This isn't it. The news is strategically positive but likely to have a neutral short-term market impact.
DCC (CDI) (DCC)
RNS Catalyst Assessment: This is a P2 announcement (AGM Trading Statement). [cite_start]It confirms Q1 trading was in line with expectations and reiterates full-year guidance for good operating profit growth, while providing an update on strategic execution including the Healthcare disposal and leadership changes. [cite: 193, 195, 198]
An in-line AGM statement from a FTSE 100 company like DCC is a neutral event. [cite_start]Reiteration of guidance removes uncertainty. [cite: 195] [cite_start]The key strategic update is the progress on simplifying the group, with the Healthcare disposal expected to complete in Q2 and a £100m share buyback underway. [cite: 198, 199] [cite_start]The ambition to become a global leader in energy products and services is clear. [cite: 197] [cite_start]With a 'Value Stock' profile (PE 10.5, EPS growth 3.1%)[cite: 646], the market values certainty and capital returns. This update delivers on both fronts, providing a solid underpinning for the share price but lacking a fresh catalyst for a significant move.
Part III: Mandatory Protocol Summary Table
Date & Time | EPIC | Company | Market Segment | Type | Key Financials | Score | Direction | Summary |
---|---|---|---|---|---|---|---|---|
10/07/25 07:00 | CAR | Carclo | FTSE All-Share | P1 | Net Debt down £10.2m | 0.0 | Neutral | Positive trading update negated by audit delay and expected share suspension. |
10/07/25 07:00 | RNK | Rank Group | FTSE 250 | P1 | Operating Profit >£63m | +9.0 | Bullish | Strong trading update with FY underlying operating profit guided to be ahead of expectations. |
10/07/25 07:01 | ATYM | Atalaya Mining | FTSE 250 | P1 | 26m @ 2.78% Cu | +6.0 | Bullish | Positive drilling results confirm and extend high-grade copper zones at Masa Valverde. |
10/07/25 07:00 | CML | CML Microsystems | AIM All-Share | P1 | Contract >$30m | +8.0 | Bullish | Secures a significant, transformative 12-year design and supply contract. |
10/07/25 07:00 | HSW | Hostelworld Group | FTSE All-Share | P1 | H1 Adj EBITDA €7.4m | +5.0 | Bullish | FY guidance reiterated, dividend reinstated, and £5m buyback announced. |
10/07/25 07:00 | PEBB | The Pebble Group | AIM All-Share | P1 | Net Cash £6.0m | +1.0 | Neutral | Trading in line with expectations, announces £6.5m tender offer. |
10/07/25 07:00 | JSG | Johnson Service Group | AIM UK 50 | P1 | H1 Revenue +5.5% | 0.0 | Neutral | In-line update with cautious tone on HORECA division's summer trading. |
10/07/25 07:00 | MACF | Macfarlane Group | FTSE All-Share | P1 | Profit warning -10% | -10.0 | Bearish | Issues profit warning due to weak demand and margin pressure. |
10/07/25 07:00 | DPP | DP Poland | AIM All-Share | P1 | H1 LFL Orders -7.0% | -1.0 | Neutral | Mixed update with sales growth offset by falling like-for-like order volumes. |
10/07/25 07:00 | POLR | Polar Capital Holdings | AIM UK 50 | P1 | Net Outflows £0.6bn | -5.0 | Bearish | Reports continued significant net outflows, overshadowing market-driven AuM growth. |
10/07/25 07:00 | SVT | Severn Trent | FTSE 100 | P1 | ODI Reward >£25m | +1.0 | Neutral | Solid, in-line trading update confirming guidance and strong operational performance. |
10/07/25 07:00 | CAML | Central Asia Metals | AIM UK 50 | P1 | Guidance cut | -6.0 | Bearish | Cuts full-year production guidance for zinc and lead at its Sasa mine. |
10/07/25 07:00 | DCC | DCC (CDI) | FTSE 100 | P2 | Q1 profit in line | +2.0 | Strategic | In-line AGM statement reiterating guidance and confirming progress on strategic simplification. |
10/07/25 07:00 | TRI | Trifast | FTSE All-Share | P1 | EBIT Margin +173bps | +7.0 | Bullish | Full-year profit performance beats expectations, driven by strong margin recovery. |
10/07/25 07:00 | VTY | Vistry Group | FTSE 250 | P1 | H1 Completions -13% | -4.0 | Bearish | H1 profits in line, but completions, sales rates, and revenue all down significantly. |
10/07/25 07:00 | LIO | Liontrust Asset Management | FTSE All-Share | P1 | Net Outflows £1.1bn | -6.0 | Bearish | Reports accelerated net outflows for the quarter, indicating continued business pressure. |
10/07/25 07:00 | PAGE | Pagegroup | FTSE 250 | P1 | Q2 GP -10.5% | -8.0 | Bearish | Q2 trading deteriorated from Q1, with worsening conditions in Europe and headcount cuts. |
10/07/25 07:00 | KETL | Strix Group | AIM All-Share | P2 | Board appointment | +2.0 | Strategic | AGM statement with no new financial data, key news is a high-quality board appointment. |
10/07/25 07:00 | CREO | Creo Medical Group | AIM All-Share | P1 | Clinical study start | +2.0 | Neutral | Positive clinical development as a new post-market study for MicroBlate Flex begins. |
10/07/25 07:00 | PANR | Pantheon Resources | AIM UK 50 | P1 | Rig mobilisation | +1.0 | Neutral | Operational update confirming rig mobilisation for a key appraisal well. |